PTI-808 is a type of CFTR modulator called a potentiator. Potentiators help facilitate the opening of the chloride channel on the cell surface to allow chloride and sodium (salt) to move in and out of the cell.
A phase 1 study to test the safety and tolerability of PTI-808 in healthy adults is underway.
This program is sponsored by Proteostasis Therapeutics. It is being conducted through the Therapeutics Development Network.
Contact us about PTI-808 >